Paper42012189
The Mycobacterium tuberculosis Rv0132c Gene Product Mtb-FGD2 Can Act as an F420-Dependent Glucose Dehydrogenase.
Aderemi AV and 12 others. Proteins, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Mycobacterium tuberculosis Rv0132c Gene Product Mtb-FGD2 Can Act as an F420-Dependent Glucose Dehydrogenase. Papers, record 42012189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42012189
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Mycobacterium tuberculosis Rv0132c Gene Product Mtb-FGD2 Can Act as an F420-Dependent Glucose Dehydrogenase.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mycobacterium tuberculosis | Major topic |
| Bacterial Proteins | Major topic |
| Glucose 1-Dehydrogenase | Major topic |
| Catalytic Domain | |
| Molecular Docking Simulation | |
| Glucose | |
| Protein Binding | |
| Crystallography, X-Ray | |
| Molecular Dynamics Simulation | |
| Recombinant Proteins | |
| Escherichia coli | |
| Cell Wall | |
| Substrate Specificity | |
| Mycolic Acids | |
| Riboflavin |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Tertiary Education Trust Fund | PubMed | |||
| BB/X019217/1 | Biotechnology and Biological Sciences Research Council | United Kingdom | PubMed | |
| BB/R009961/1 | Biotechnology and Biological Sciences Research Council | United Kingdom | PubMed | |
| BB/I019227/1 | Biotechnology and Biological Sciences Research Council | United Kingdom | PubMed |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,846,552 | The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19846552 | PubMed |
| 2 | 20,675,471 | Unexpected abundance of coenzyme F(420)-dependent enzymes in Mycobacterium tuberculosis and other actinobacteria. | J Bacteriol | 2010 | https://conductscience.org/library/papers/20675471 | PubMed |
| 3 | 17,376,702 | Expression, purification and crystallization of native and selenomethionine labeled Mycobacterium tuberculosis FGD1 (Rv0407) using a Mycobacterium smegmatis expression system. | Protein Expr Purif | 2007 | https://conductscience.org/library/papers/17376702 | PubMed |
| 4 | 35,342,000 | Drug resistant TB - latest developments in epidemiology, diagnostics and management. | Int J Infect Dis | 2022 | https://conductscience.org/library/papers/35342000 | PubMed |
| 5 | 8,631,674 | Purification of a novel coenzyme F420-dependent glucose-6-phosphate dehydrogenase from Mycobacterium smegmatis. | J Bacteriol | 1996 | https://conductscience.org/library/papers/8631674 | PubMed |
| 6 | 24,637,771 | Crystallization and preliminary X-ray crystallographic analysis of latent isoform PPO4 mushroom (Agaricus bisporus) tyrosinase. | Acta Crystallogr F Struct Biol Commun | 2014 | https://conductscience.org/library/papers/24637771 | PubMed |
| 7 | 25,644,473 | Molecular insights into the binding of coenzyme F420 to the conserved protein Rv1155 from Mycobacterium tuberculosis. | Protein Sci | 2015 | https://conductscience.org/library/papers/25644473 | PubMed |
| 8 | 23,240,649 | A novel F(420) -dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agents. | Mol Microbiol | 2013 | https://conductscience.org/library/papers/23240649 | PubMed |
| 9 | 17,212,484 | Canonical sampling through velocity rescaling. | J Chem Phys | 2007 | https://conductscience.org/library/papers/17212484 | PubMed |
| 10 | 11,257,493 | The TIM-barrel fold: a versatile framework for efficient enzymes. | FEBS Lett | 2001 | https://conductscience.org/library/papers/11257493 | PubMed |
| 11 | 23,110,042 | Tat-dependent translocation of an F420-binding protein of Mycobacterium tuberculosis. | PLoS One | 2012 | https://conductscience.org/library/papers/23110042 | PubMed |
| 12 | 17,935,691 | Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane--distinct translocases and mechanisms. | Biochim Biophys Acta | 2008 | https://conductscience.org/library/papers/17935691 | PubMed |
| 13 | 30,952,857 | A revised biosynthetic pathway for the cofactor F420 in prokaryotes. | Nat Commun | 2019 | https://conductscience.org/library/papers/30952857 | PubMed |
| 14 | 29,949,628 | The crystallization additive hexatungstotellurate promotes the crystallization of the HSP70 nucleotide binding domain into two different crystal forms. | PLoS One | 2018 | https://conductscience.org/library/papers/29949628 | PubMed |
| 15 | 40,952 | Distribution of coenzyme F420 and properties of its hydrolytic fragments. | J Bacteriol | 1979 | https://conductscience.org/library/papers/40952 | PubMed |
| 16 | 22,244,759 | Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824. | Structure | 2012 | https://conductscience.org/library/papers/22244759 | PubMed |
| 17 | 28,620,367 | Mycobacterial F420H2-Dependent Reductases Promiscuously Reduce Diverse Compounds through a Common Mechanism. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28620367 | PubMed |
| 18 | 32,192,585 | Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. | Lancet Respir Med | 2020 | https://conductscience.org/library/papers/32192585 | PubMed |
| 19 | 19,399,780 | AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. | J Comput Chem | 2009 | https://conductscience.org/library/papers/19399780 | PubMed |
| 20 | 26,574,453 | ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. | J Chem Theory Comput | 2015 | https://conductscience.org/library/papers/26574453 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42012189
GET https://conductscience.org/api/papers/v1/42012189/references?page=2